ACR assails cardiology-backed study of utilization

Article

The American College of Radiology has criticized a study that allegedly misrepresents the reasons for rapidly rising imaging utilization.

The American College of Radiology has criticized a study that allegedly misrepresents the reasons for rapidly rising imaging utilization.

A report by the Lewin Group on Medicare costs, sponsored by the Coalition for Patient-Centered Imaging, found that hospital and outpatient services-not self-referrals by nonradiologists-are responsible for rising Medicare costs. The CPCI comprises cardiologists and other nonradiologists who perform medical imaging.

In a press release, Dr. James P. Borgstede, chair of the ACR's board of chancellors, said that the analysis did not adequately address concerns in Congress that growing in-office imaging might be responsible for rising costs. The study also ignores a decade's worth of data on booming self-referral imaging by nonradiologists, he said.

Jill Rathbun, spokesperson for the American Society of Breast Surgeons, a CPCI member, defended the report, saying it looks at the big picture rather than concentrating on Medicare physician fee schedules as a source of imaging growth.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.